Clinical Trial Update: European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata [Phase 3]

View source ↗

Summary

The European extension of the Phase 3 trial evaluating CTP-543 for alopecia areata has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• CTP-543

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Alopecia Areata | Phase 3 | Status: COMPLETED | Results posted: 2025-11-21